Solpura liprotamase regulatory update

FDA's Gastrointestinal Drugs Advisory Committee will meet on Jan. 12 to discuss an NDA from Eli Lilly for Solpura liprotamase capsules to treat exocrine pancreatic insufficiency (EPI). The pharma gain...